The Potential Role of Sfrp5 in the Treatment of Obesity

Image

The Potential Role of Sfrp5 in the Treatment of Obesity

Obesity is frequently defined as excess body weight for a given height, which has become a central issue for the global health concern. Secreted frizzled‐related protein 5 (SFRP5) is an anti‐inflammatory adipokine secreted by adipocytes, which has been regarded as a “good” a adipokine that could promotes good health. Researchers believed that SFRP5 could become the therapeutic target for the treatment of obesity, which takes effect through SFRP5/Wnt pathway. The purpose of this review is to summarize the effects of SFRP5, including being the signature of obesity, inhibiting adipogenesis, regulating triglyceride metabolism and alleviating inflammation, which is important for our increased understanding of the potential therapeutic role of SFRP5 in metabolic disease.

Keywords: SFRP5; Obesity; Signature of obesity; Adipogenesis; Triglyceride metabolism; Inflammation

Full length article: https://www.imedpub.com/articles/the-potential-role-of-sfrp5-in-the-treatment-of-obesity.pdf

Endocrinology and Metabolism: Open Access is a peer reviewed journal which focuses on the publication of current research and developments on the endocrine glands and its secretions with their coordination with metabolism and reproduction.

Endocrinology and Metabolism: Open Access Journal is using Editorial Tracking System to maintain quality and transparency to the author in the peer-review process. Review processing will be performed by the editorial board members of the Journal Endocrinology and Metabolism: Open Access or by Reviewers (outside experts in the field). Two independent reviewer’s approval (Minimum reviewer’s approval) followed by editor approval is obligatory for acceptance of any manuscript excluding an editorial.

Journal is now accepting manuscripts for volume 5 for year 2021. We publish minimum of 5 and maximum of 20 articles per issue every month. Submissions to our journal are given high priority during the process.

Submit your manuscript at:

https://www.imedpub.com/submissions/endocrinology-metabolism-open-access.html 

You may also send the manuscript as an attachment to mail endometabol@emedscholar.com

Media Contact
Eliza Grace
Associate Managing Editor
Endocrinology and Metabolism: Open Access
E-Mail: 
endometabol@emedscholar.com